Prednisone therapy in Becker's muscular dystrophy

Area of Science:

• Neurology
• Genetics
• Biochemistry

Background:

• Becker's muscular dystrophy is a genetic disorder characterized by progressive muscle weakness.
• Xp-21 gene defects are associated with Becker's muscular dystrophy.
• Current treatments for Becker's muscular dystrophy are limited.

Observation:

• Two boys diagnosed with Becker's muscular dystrophy showed remarkable strength gains with prednisone therapy.
• Serum creatine kinase levels decreased concurrently with strength improvement.
• Muscle biopsies revealed changes in dystrophin quantity and histology consistent with treatment efficacy.

Findings:

• Prednisone treatment led to dramatic and sustained improvement in muscle strength in these patients.
• A decrease in serum creatine kinase levels correlated with clinical improvement.
• Histological and immunoblot analysis of muscle biopsies indicated a positive response to prednisone.

Implications:

• Therapeutic corticosteroids, specifically prednisone, may be beneficial for a subset of Becker's muscular dystrophy patients.
• All patients with Becker's muscular dystrophy should consider a trial of prednisone to assess potential benefits.
• This finding could lead to revised treatment guidelines for Becker's muscular dystrophy.